Alloy Therapeutics, Inc. — Form D

Alloy Therapeutics, Inc. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2026-04-15. The offering totals $40.0M, of which $30.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Errik B. AndersonRelated PersonCambridge, MA
Piotr BobrowiczRelated PersonWALTHAM, MA
Jason CammRelated PersonWALTHAM, MA
Jason ColomaRelated PersonAUSTIN, TX
Alaa HalawaRelated PersonAUSTIN, TX
Christian KanadyRelated PersonOklahoma City, OK
Alex KolicichRelated PersonWALTHAM, MA
Ulrik NielsenRelated PersonWALTHAM, MA
Logan SnyderRelated PersonWALTHAM, MA
Anthony SunRelated PersonApex, NC
Jason ColomaDirectorAUSTIN, TX
Anthony B SunDirectorWALTHAM, MA
Alaa B HalawaDirectorWALTHAM, MA
Ulrik B NielsenDirectorWALTHAM, MA
Piotr B BobrowiczDirectorWALTHAM, MA
Piotr B BobrowiczExecutive OfficerWALTHAM, MA
Jason B CammDirectorWALTHAM, MA
Logan B SnyderDirectorWALTHAM, MA
Logan B SnyderExecutive OfficerWALTHAM, MA
Fabian B HansenDirectorWALTHAM, MA
Alex B KolicichDirectorWALTHAM, MA
Jay B RosanelliExecutive OfficerLEXINGTON, MA
Errik B AndersonDirectorLEBANON, NH
Errik B AndersonExecutive OfficerLEBANON, NH

Other filings by this issuer (2)

FiledFormOfferingSold
2022-10-03D$41.7M$41.7M
2021-04-02D$75.0M$75.0M

More